Dawn or Doom ’17 keynote to discuss benefits, pitfalls of biotechnology

With the recent news that scientists in the United States have used CRISPR gene editing technology to remove a disease-causing mutation from the DNA of a human embryo for the first time, many life-saving biotechnology breakthroughs seem closer than ever before.

But with those advances come the potential for much harm, if we don’t tread carefully, says Michael Bess, the Chancellor’s Professor of History at Vanderbilt University and author of the book “Our Grandchildren Redesigned: Life in the Bioengineered Society of the Near Future.”Michael Bess

“The most blatant risk to me is exacerbating the gap between the rich and the poor,” Bess says. “With the emergence of a biologically-based caste system, where some people have the ability to amplify themselves up to higher levels and the poor get left behind, we’d be taking the inequality that exists in our society and writing it into our very biology.”

Bess will discuss the potential benefits and pitfalls of recent breakthroughs in biotechnology during Dawn or Doom ’17, a conference on the risks and rewards of emerging technology. Dawn or Doom will be held Tuesday and Wednesday, Sept. 26 and 27, on the Purdue West Lafayette campus and is free and open to the public.

Dawn or Doom, which includes a track called Designing Humans: Bioengineering and Human Design, also will include featured talks by Robb Fraley, chief technology officer at Monsanto and a World Food Prize winner, Nicolas Thompson, WIRED Editor-in-Chief, Quentin Hardy, Google’s head editor, and Tom Bradicich, vice president and general manager of Hewlett Packard Enterprise. Other tracks at the conference include Designing Food, Designing Cities, Designing Information and Designing the Workforce. Visit www.purdue.edu/dawnordoom for more information.    

The biggest “dawn” Bess foresees from biotechnological enhancements in such areas as pharmaceuticals, bioelectronics and epigenetics sounds great: the ability to live “healthful, vigorous, mentally clear lives for decades longer than we do now.” But that “dawn” is not without a great deal of potential “doom.”

Inequality is not the only risk that worries Bess. He also fears that these technologies could erode our sense of human individuality, leading us to treat people like commodities whose self-worth is determined only by their capabilities.

“You can slip rather easily into a mentality that becomes coldly comparative and forgets to respect people in basic ways,” says Bess.

Bess was motivated to research these topics when he was captivated by the character Data, a human-like android on the TV series Star Trek: The Next Generation. He initially set out to write about artificial intelligence and the possibility of machines achieving human-like personality traits, but as he began researching the subject, he realized that the possibility of humans modifying our own biology presented an even more pressing issue.

But even in the field of biotechnology, machines are ever present. In his book, Bess discusses some of the ways they may intersect with us, including through research that’s demonstrated that humans have the ability to control robotic limbs with our minds.

“I think people underestimate just how profoundly we’re going to be merging with our machines over the coming years,” he says.

Writer:  Adrienne Miller, science and technology writer, Information Technology at Purdue (ITaP), 765-496-8204, mill2027@purdue.edu

Last updated: August 22, 2017

Purdue University, 610 Purdue Mall, West Lafayette, IN 47907, (765) 494-4600

© 2015 Purdue University | An equal access/equal opportunity university | Copyright Complaints | Maintained by ITaP

Trouble with this page? Disability-related accessibility issue? Please contact ITaP at itap@purdue.edu.